Axovant Sciences (NASDAQ: AXON) today announced the pricing of its underwritten public offering of 30,000,000 of its common shares at ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE